Company profile: Conavi Medical
1.1 - Company Overview
Company description
- Provider of image guidance technologies for minimally invasive cardiovascular procedures, including catheter-based ultrasound that generates 2-D and 3-D images of intracardiac and intravascular anatomy around the catheter tip, and the Novasight Hybrid System, which combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
Products and services
- Catheter-Based Ultrasound Imaging System: Produces 360-degree 2-D and 3-D ultrasound images of cardiac anatomy around the catheter tip to visualize intracardiac and intravascular systems for directing minimally invasive procedures
- Image Guidance Technology Platform: Delivers clinical-grade systems to direct minimally invasive cardiovascular procedures by visualizing intracardiac and intravascular using catheter-based ultrasound with 2-D and 3-D imaging around the catheter tip
- Novasight Hybrid System: Engineers a custom-engineered imaging product combining intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to deliver image guidance for minimally invasive cardiovascular procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Conavi Medical
ReCor Medical
HQ: United States
Website
- Description: Provider of a therapeutic non-focused ultrasound system for renal denervation in resistant hypertension. Offers the PARADISE Percutaneous Renal Denervation System with a 6 French catheter and cylindrical transducer emitting circumferential ultrasound, the SonoWave 360 Transducer, HydroCooling System, clinical trials proving effectiveness, and reimbursement resources for coding and coverage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReCor Medical company profile →
InnAVasc
HQ: United States
Website
- Description: Provider of medical devices for vascular access in hemodialysis, focusing on immediate access, home hemodialysis, and dialysis needle protection; offering the InnAVasc Graft with protective backplates and self-sealing materials to prevent needle injuries and bleeding complications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnAVasc company profile →
Invatec
HQ: United States
Website
- Description: Provider of interventional coronary and peripheral products, focused on the development and commercialization of research-driven technologies. Headquartered in Europe, the company collaborates with physicians and centers of excellence to create products aimed at improving life expectancy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invatec company profile →
CorWave
HQ: France
Website
- Description: Provider of biomimetic heart pumps and cardiac support devices, including the CorWave LVAD for advanced heart failure that uses an undulating disc wave mechanism to deliver pulsatile, physiological blood flow with less blood trauma, reducing clotting and bleeding complications; Nemo, a compact, minimally invasive device for partial heart failure support; and Wave Membrane Technology enabling physiological flow and pulsatility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CorWave company profile →
Calon Cardio
HQ: United Kingdom
Website
- Description: Provider of implantable micro blood pumps for the treatment of chronic heart failure. Its Calon MiniVAD is a miniature implantable pump placed in the left ventricle to help provide blood supply to the body, alleviate debilitating symptoms, improve blood flow, and reduce complications such as blood damage and thrombus formation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calon Cardio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Conavi Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Conavi Medical
2.2 - Growth funds investing in similar companies to Conavi Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Conavi Medical
4.2 - Public trading comparable groups for Conavi Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →